New from the blog
Introducing the new Aescuvest
The first digital health dedicated, pan-European, deal-by-deal, FinTech platform for professional health investors.
What investors can still rely on in times like this
It has been stated over and over that investing during times of strong economic growth is fairly easy: every investor who can make reasonable choices and stick to the best practices will get wealthier. But in times of declining economic stability and approaching recession, investing gets tough again.
The future of clinical trials: Digging into the potential of Big Data
“Aescuvest is on a mission to facilitate and enable impactful investments into medical breakthrough innovation with the potential of disrupting and dramatically improving healthcare delivery models, products, and services. The future of clinical trials most certainly can be shaped by innovation through Big Data and AI. We believe in a future of health that is built by intelligent, digital solutions resulting in a better world for patients. This led us to the start-up XO-Life.” – Dr. Patrick Pfeffer
Consumer Adoption in Digital Health: It is happening (with or without you)
1. Global healthcare systems overcame times of enormous workload – But Germany is lacking in efficiency. 2. The lack of data is real: Germany struggled to make substantiated statements about vaccination efficiency due to slow moving (or not moving) data. 3. The times of paper vaccination booklets and fax devices are over. 4. Digital health can aid in overcoming demographic challenges that our society is facing more and more by making healthcare services more (cost and time) efficient.
The „Fail Fast Culture“ – Reasons start-ups fail and how to prevent it from happening
A prime example: The media covered it enough already – but Theranos is just a very good example of big-time failure. The American healthcare start-up was an established company with prestigious investors having their stakes in the business already when it broke down just recently. Why? Due to fraud and dishonesty from the management: one of many reasons a start-up can potentially fail in the short-term or in the long-run. As an investor, you want to make sure to limit your risks by thoroughly investigating the company you are about to be a part of.
Metaverse: A brave new world – How digital copies can revolutionize healthcare
Let’s go back to the beginnings of the internet: HTML, HTTP and URL were the tools used to build a world besides our world – we actually created the metaverse back then already. The next wave of innovation brought us CSS, Java Script and HTML5 with the added functionality of now being able to contribute to the network instead of only consume it. Big change!
The Prevalence of Chronic Diseases – How Healthcare Innovation will save more lives
Approximately 537 million adults are living with diabetes worldwide. In Germany there are 9.5 million which is 15.3% of the population! The numbers continue to rise. Germany is ranked in the top 10 global countries with the fastest growth in diabetes. Additionally, almost one in two people in Germany over 15 years of age reports living with two or more chronic conditions. According to the European Observatory on Health Systems and Policies, one in six adults are considered to be obese in Germany.
The transformation of the healthcare landscape
Over the last 5 years, big tech has massively increased its healthcare investment: 12 times more healthcare-related mergers, acquisitions, partnerships, or ventures took place! By 2030, healthcare will look entirely different than what we have seen over the past decade.
DiGA then and now – How European Healthcare is entering the digital age
Meanwhile in Finland… More than 20 years. This is how long Finland is using an electronic patient record already. The citizen of the north are used to receiving medical services like consultations and check-ups fully digital besides going to the doctor physically when necessary.
State of Digital Health – Digitalization in Healthcare is advancing rapidly
What is true in evolution appears to be a law that serves quite well in business as well: the companies that outperform are the ones that give the returns you as an investor are looking for. It is fair to say that finding those companies at a stage where they are “affordable” for investors is an art practiced by just a few – and even for them there is a good chunk of luck involved. But one can increase the chances of luck by gathering the right information at the right time to make right decisions. Currently we can observe which innovations and business models of the past 2 years will survive and set themselves up for sustainable success looking forward.